Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

Abstract Objective To determine COVID-19 vaccine-related adverse events (AEs) in the seven-day post-vaccination period in patients with SLE vs autoimmune rheumatic diseases (AIRDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HC). Methods Data were captured through the COVID-19...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology (Oxford, England) England), 2023-07, Vol.62 (7), p.2453-2463
Hauptverfasser:	Naveen, R, Nikiphorou, Elena, Joshi, Mrudula, Sen, Parikshit, Lindblom, Julius, Agarwal, Vishwesh, Lilleker, James B, Tan, Ai Lyn, Salim, Babur, Ziade, Nelly, Velikova, Tsvetelina, Gracia-Ramos, Abraham Edgar, Kuwana, Masataka, Day, Jessica, Makol, Ashima, Distler, Oliver, Chinoy, Hector, Traboco, Lisa S, Wibowo, Suryo Anggoro Kusumo, Tehozol, Erick Adrian Zamora, Serrano, Jorge Rojas, García-De La Torre, Ignacio, Aggarwal, Rohit, Gupta, Latika, Agarwal, Vikas, Parodis, Ioannis
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult adverse events Autoimmune Diseases Chills Clinical Science COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects Exanthema Female Fever Hospitalization Humans Immunological tolerance Lupus Erythematosus, Systemic Male Regression analysis SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Systemic lupus erythematosus Vaccination - adverse effects vaccine Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!